System for charge-based detection of nucleic acids
ZA200005873B
Topical formulation comprising poloxamers and further microbicides, and an applicator.
CA2270600A1
Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
NZ527295A
Applicator for delivering a liquid or semi-solid topical formulation into a mucosal cavity, for example, a vagina
CZ20003899A3
Preparations for prevention or therapy of diseases afflicting mucous membranes or skin or for prevention of impregnation and applicator for administering local preparations in mucous membrane cavities
NZ507609A
Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
CA2591758A1
Applicator for the delivery of topical formulation into mucosal cavities
CA2257001A1
Method and formulations for prevention of infection of mucosae and/or skin and development of a vaginal/ano-rectal applicator for the delivery of topical formulations
AU2629997A
Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
